Home
About
FAQ
History (2)
Co-Principal Investigator
Tildrakizumab: A Review of Phase II and III Clinical Trials.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-Principal Investigator
Overview
researcher role of
Whitlow, Christopher
contributes to
Beta-Amyloid Clearance Mapping in Alzheimer?s Disease